126 related articles for article (PubMed ID: 3566356)
21. Comparison of hormone transfer to pleural and synovial exudates.
Rovensky J; Simorova E; Radikova Z; Imrich R; Greguska O; Vigas M; Macho L
Endocr Regul; 2006 Jun; 40(2):29-36. PubMed ID: 17100544
[TBL] [Abstract][Full Text] [Related]
22. Fibronectin concentrations in pleural effusions of patients with malignant and non-malignant diseases.
Siri A; Carnemolla B; Raffanti S; Castellani P; Balzano E; Zardi L
Cancer Lett; 1984 Feb; 22(1):1-9. PubMed ID: 6421478
[TBL] [Abstract][Full Text] [Related]
23. [Significance of detecting E-selectin of serum and pleural effusion in differentiating benign and malignant diseases].
Liu G; Li C; Zhong X
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):556-8. PubMed ID: 11360510
[TBL] [Abstract][Full Text] [Related]
24. Hyaluronan in pleural effusions and in serum.
Hillerdal G; Lindqvist U; Engström-Laurent A
Cancer; 1991 May; 67(9):2410-4. PubMed ID: 2013045
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical detection of pregnancy-specific protein (SP1) and placenta-specific tissue proteins (PP5, PP10, PP11 and PP12) in ovarian adenocarcinomas.
Inaba N; Ishige H; Ijichi M; Satoh N; Ohkawa R; Sekiya S; Shirotake S; Takamizawa H; Renk T; Bohn H
Oncodev Biol Med; 1982; 3(5-6):379-89. PubMed ID: 6755403
[TBL] [Abstract][Full Text] [Related]
26. Oncofetal antigens in ovarian cyst fluids.
Kraly DH; Koh SH; Hay DL; Cauchi MN
Gynecol Obstet Invest; 1984; 18(3):117-21. PubMed ID: 6208091
[TBL] [Abstract][Full Text] [Related]
27. Placental protein 4 as a possible tumor marker in ovarian tumors.
Göcze PM; Szabò DG; Than GN; Krommer KF; Csaba IF; Bohn H
Gynecol Obstet Invest; 1991; 32(2):107-11. PubMed ID: 1836196
[TBL] [Abstract][Full Text] [Related]
28. [Transudative pleural effusions and the ovarian hyperstimulation syndrome].
Boutemy M; Buklow K; Glérant JCh; Martin F; Jounieaux V
Rev Mal Respir; 2003 Feb; 20(1 Pt 1):134-9. PubMed ID: 12709642
[TBL] [Abstract][Full Text] [Related]
29. The chemotactic cytokine interleukin-8--a cyst fluid marker for malignant epithelial ovarian cancer?
Ivarsson K; Runesson E; Sundfeldt K; Haeger M; Hedin L; Janson PO; Brännström M
Gynecol Oncol; 1998 Dec; 71(3):420-3. PubMed ID: 9887242
[TBL] [Abstract][Full Text] [Related]
30. Ectopic synthesis of pregnancy specific beta 1-glycoprotein (SP1) and placental specific tissue proteins (PP5, PP10, PP11, PP12) in nontrophoblastic malignant tumours. Possible markers in oncology.
Inaba N; Renk T; Wurster K; Rapp W; Bohn H
Klin Wochenschr; 1980 Aug; 58(15):789-91. PubMed ID: 6160287
[TBL] [Abstract][Full Text] [Related]
31. Role of MCP-1 in pleural effusion development in a carrageenan-induced murine model of pleurisy.
Lansley SM; Cheah HM; Lee YC
Respirology; 2017 May; 22(4):758-763. PubMed ID: 27878909
[TBL] [Abstract][Full Text] [Related]
32. Tumor markers in inclusion cysts of the ovary.
Blaustein A; Kaganowicz A; Wells J
Cancer; 1982 Feb; 49(4):722-6. PubMed ID: 7034921
[TBL] [Abstract][Full Text] [Related]
33. Exudative pleural effusion: effectiveness of pleural fluid analysis and pleural biopsy.
Heidari B; Bijani K; Eissazadeh M; Heidari P
East Mediterr Health J; 2007; 13(4):765-73. PubMed ID: 17955757
[TBL] [Abstract][Full Text] [Related]
34. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
Klech H; Rona G; Hutter C; Bayer PM; Kummer F
Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
[TBL] [Abstract][Full Text] [Related]
35. Gelatinolytic activities (matrix metalloproteinase-2 and -9) and soluble extracellular domain of Her-2/neu in pleural effusions.
Di Carlo A; Mariano A; Terracciano D; Mazzarella C; Galzerano S; Cicalese M; Cecere C; Macchia V
Oncol Rep; 2007 Aug; 18(2):425-31. PubMed ID: 17611666
[TBL] [Abstract][Full Text] [Related]
36. Cancer-associated antigen CA 195 in patients with mucinous ovarian tumours: a comparative analysis with CEA, TATI and CA 125 in serum specimens and cyst fluids.
de Bruijn HW; ten Hoor KA; Boonstra H; Marrink J; Krans M; Aalders JG
Tumour Biol; 1993; 14(2):105-15. PubMed ID: 8392219
[TBL] [Abstract][Full Text] [Related]
37. The value of cyst puncture in the differential diagnosis of benign ovarian tumours.
Vercellini P; Oldani S; Felicetta I; Bramante T; Rognoni MT; Crosignani PG
Hum Reprod; 1995 Jun; 10(6):1465-9. PubMed ID: 7593516
[TBL] [Abstract][Full Text] [Related]
38. [Pleural effusion].
Thomas P; Castelnau O; Kleisbauer JP
Rev Mal Respir; 1998 Jun; 15(3 Pt 2):363-7. PubMed ID: 9690306
[TBL] [Abstract][Full Text] [Related]
39. [Clinical evaluation of benign asbestos pleurisy].
Kishimoto T; Okahara M; Chikamori K; Ozaki S; Aoe K; Ohke M; Fujioka H; Kimura K; Yonei T
Nihon Kokyuki Gakkai Zasshi; 1998 Jan; 36(1):18-22. PubMed ID: 9611971
[TBL] [Abstract][Full Text] [Related]
40. Serum and cyst fluid levels of interleukin (IL) -6, IL-8 and tumour necrosis factor-alpha in women with endometriomas and benign and malignant cystic ovarian tumours.
Daraï E; Detchev R; Hugol D; Quang NT
Hum Reprod; 2003 Aug; 18(8):1681-5. PubMed ID: 12871882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
